Live Breaking News & Updates on டெக்சாஸ் கல்லீரல் நிறுவனம்

Stay updated with breaking news from டெக்சாஸ் கல்லீரல் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UT Health San Antonio professors urge uplifting US Latinos from obscurity to the forefront of health care

It is essential to lift the nation's Latino population from obscurity to the forefront of health care, public health intervention and societal presence, three professors from The University of Texas Health Science Center at San Antonio argue in a powerful commentary published Aug. 17 by the Journal of the American Medical Association. ....

United States , San Antonio , Rita Lepe , Howard Koh , David Satcher , Ebony Boulware , Emily Henderson , Franciscog Cigarroa , Mays Cancer Center , Department Of Population Health Sciences , Us Centers For Disease , Us Health Resources , Ut Health San Antonio Transplant Center , Inclusion In Health Care , Journal Of The American Medical Association , Institute For Health Promotion Research , Ford Foundation , Texas Liver Institute , Services Administration , Teresa Lozano Long School Of Medicine , Texas Health Science Center , American Medical Association , Teresa Lozano Long School , Disease Control , Health Promotion Research , Population Health Sciences ,

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science
pressreleasepoint.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressreleasepoint.com Daily Mail and Mail on Sunday newspapers.

Mount School , United States , New York , San Diego , Los Angeles , Julio Gutierrez , Marcus Hompesch , University Of Miami School Medicine , University Of California , Vincent Medical Center , Texas Liver Institute , Mount Sinai School Of Medicine , Prosciento Inc , Clinical Research , Vice President , Medical Director , Liver Transplant , Adjunct Assistant Professor , Sharp Healthcare , Hepatobiliary Cancer , Direct Acting Antivirals , Medical Degree , Mount Sinai School , New York City , Miami School , ஏற்ற பள்ளி ,

DURECT Corporation to Present Additional Clinical Data from DUR-928 Studies in NASH (Phase 1b) and in Hepatic Impairment (Phase 1) at Upcoming International Liver Conference 2021 (EASL)

Share this article
Share this article
CUPERTINO, Calif., June 9, 2021 /PRNewswire/ DURECT Corporation (Nasdaq: DRRX) today announced it will present two posters at the 2021
The first poster will discuss additional efficacy signals from a Phase 1b clinical study of orally administered DUR-928 in nonalcoholic steatohepatitis (NASH) patients. Previously reported data showed that DUR-928 was well tolerated at all three doses evaluated, 50mg QD, 150mg QD, and 300mg BID (600mg/day) with overall improvement from baseline observed in liver enzymes, serum lipid profiles, liver fat by imaging, and biomarkers of liver health. The poster will feature additional efficacy signal data including liver stiffness by transient elastography (TE) and magnetic resonance elastography (MRE), liver fibrosis marker, pro-C3, and ELF scores, as well as insulin resistance (HOMA-IR). ....

United States , Eric Lawitz , Jaymin Shah , Texas Liver Institute , Drug Administration , International Liver Conference , Corporation Nasdaq , Research Development , Liver Conference , Presentation Details , Week Oral , Vice President , Texas Liver , Executive Director , Clinical Pharmacology , Fast Track , Boxed Warning , Looking Statement , Durect Corporation , ஒன்றுபட்டது மாநிலங்களில் , ஜெய்மின் ஷா , டெக்சாஸ் கல்லீரல் நிறுவனம் , சர்வதேச கல்லீரல் மாநாடு , நிறுவனம் நாஸ்டாக் , ஆராய்ச்சி வளர்ச்சி , ப்ரெஸெஂடேஶந் விவரங்கள் ,